|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2003-5-20
|
|
pubmed:abstractText |
Hepatocyte growth factor (HGF) is implicated in tissue regeneration, angiogenesis, and antiapoptosis. However, its chronic effects are undetermined on postinfarction left ventricular (LV) remodeling and heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:EsakiMasayasuM,
pubmed-author:FujiwaraHisayoshiH,
pubmed-author:FujiwaraTakakoT,
pubmed-author:GotoKazukoK,
pubmed-author:HayakawaKenjiK,
pubmed-author:KawaseYukinoriY,
pubmed-author:KodaMasahikoM,
pubmed-author:KosaiKen-ichiroK,
pubmed-author:LiYiwenY,
pubmed-author:MaruyamaRumiR,
pubmed-author:MinatoguchiShinyaS,
pubmed-author:MizuguchiHiroyukiH,
pubmed-author:NaganoSatoshiS,
pubmed-author:OkadaHideshiH,
pubmed-author:TakahashiTomoyukiT,
pubmed-author:TakemuraGenzouG,
pubmed-author:YugeKentaroK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2499-506
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12695295-Adenoviridae,
pubmed-meshheading:12695295-Animals,
pubmed-meshheading:12695295-Bromodeoxyuridine,
pubmed-meshheading:12695295-Cell Division,
pubmed-meshheading:12695295-Chronic Disease,
pubmed-meshheading:12695295-Disease Models, Animal,
pubmed-meshheading:12695295-Disease Progression,
pubmed-meshheading:12695295-Genetic Vectors,
pubmed-meshheading:12695295-Hepatocyte Growth Factor,
pubmed-meshheading:12695295-Hepatocytes,
pubmed-meshheading:12695295-Humans,
pubmed-meshheading:12695295-Immunohistochemistry,
pubmed-meshheading:12695295-Male,
pubmed-meshheading:12695295-Mice,
pubmed-meshheading:12695295-Mice, Inbred C57BL,
pubmed-meshheading:12695295-Myocardial Infarction,
pubmed-meshheading:12695295-Myocardium,
pubmed-meshheading:12695295-Survival Rate,
pubmed-meshheading:12695295-Time Factors,
pubmed-meshheading:12695295-Transduction, Genetic,
pubmed-meshheading:12695295-Treatment Outcome,
pubmed-meshheading:12695295-Ventricular Dysfunction, Left,
pubmed-meshheading:12695295-Ventricular Remodeling
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
|
|
pubmed:affiliation |
Second Department of Internal Medicine, Gifu University School of Medicine, 40 Tsukasa-Machi, Gifu 500-8705, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
